Current Research in
TOXOCOLOGY
Editorial Board
Editor-in-Chief
Dr. Thomas Knudsen, PhD
National Center for Computational Toxicology, Research Triangle Park,
North Carolina, United States
Associate Editor
Professor Mathieu Vinken, PhD; PharmD; ERT
Vrije University Brussel, Department of In Vitro Toxicology, Brussels,
Belgiumin vitro toxicology, mechanistic toxicology, liver toxicology,
cellular signalling
Editorial Manager
Editorial Board Members
Assoc. Professor Randolph Ashton, PhD
University of Wisconsin, Biomedical Engineering & Wisconsin Institute
for Discovery, Madison, Wisconsin, United StatesNeural stem cells,
human pluripotent stem cells, neural tissue engineering, biomaterials
Dr. Marcelo Asprea, PhD
Pediatrics Hospital Prof. Dr. Juan P. Garrahan, Chief of Bioterio and
Experimental Surgery, Buenos Aires, ArgentinaIn Vitro Toxicology
Prof. Dr. Holger Barth, PhD
University Hospital Ulm Institute of Pharmacology and Toxicology, Ulm,
GermanyBacterial protein toxins, their interaction with mammalian cells
and their membrane transport inside cells.
Dr. David G. Belair, PhD; DABT
AbbVie Inc, North Chicago, Illinois, United StatesBiomaterials, Stem
cells, Complex in vitro models, Microphysiological systems, Drug
discovery toxicology
Prof. Dr. Martin van den Berg, PhD
Utrecht University Institute for Risk Assessment Sciences, Utrecht,
NetherlandsHuman Risk Assessment, Cancer risk assessment, Pesticides,
Endocrine disruptors, Environmental Contaminants, Dioxins, Persistent
Organic Pollutants, Environmental Toxicology, Food Contamination,
Flameretardants, Mixture toxicity, Developmental and Reproductive
Toxicology
Professor Felix Carvalho, PhD; PharmD
University of Porto Faculty of Pharmacy, Porto, PortugalToxicology,
Pharmacology, Pharmacy, Drug Abuse
Dr. George Daston, PhD
Procter and Gamble Co, Cincinnati, Ohio, United
StatesPharmacogenomics, Toxicogenomics, Genotoxicity, Chemical
carcinogenesis
Prof. Dr. Daniel R. Dietrich, PhD
University of Constance Human and Environmental Toxicology,
Konstanz, GermanyRenal Carcinogenesis, Pathology Natural
compounds
Dr. Lorna Ewart, PhD
Emulate Inc, Cambridge, Massachusetts, United StatesToxicology,
Pharmacology, Drug Discovery, Organ Chips, In vitro
Prof. Dr. Ellen Fritsche, PhD; MD
IUF – Leibniz Research Institute for Environmental Medicine,
Dusseldorf, GermanyDevelopmental Neurotoxicity, In Vitro, Adverse
Outcome Pathway, Thyroid hormone disruption, Signalling Pathways,
Neurospheres
Dr. Helena Kandarova, PhD; ERT
Slovak Academy of Sciences, Centre for Experimental Medicine
SAS, Bratislava, SlovakiaTopical toxicity, Toxicology, In Vitro, Tissue
engineering, Validation, Regulatory acceptance, Alternative methods
Professor Wilma G. Kempinas, B.Sc; M.Sc; PhD
Sao Paulo State University Julio de Mesquita Filho Department
of Morphology, BOTUCATU, BrazilReproductive toxicology,
Developmental toxicology
Dr. Hajime Kojima, PhD
National Institute of Health Sciences, Tokyo, JapanIn Vitro Toxicology,
Genotoxicity, Local Toxicity
Dr. Christopher Lau, PhD
US Environmental Protection Agency National Health and
Environmental Effects Research Laboratory, Research Triangle Park,
North Carolina, United StatesCharacterizing the chemically induced
reproductive toxicity and developmental toxicity during embryonic and
perinatal life stages, understanding of their modes of action, and applying
such information to human health risk assessment
Professor Pamela J. Lein, MSEH; PhD
University of California Davis Department of Molecular Biosciences,
Davis, California, United Statesair pollution, chemical-induced seizures,
developmental neurotoxicity, neurodegeneration, neuroinflammation,
neurotoxicology, organophosphates, persistent organic pollutants
Dr. Susan E. Maier, PhD
National Institute of Allergy and Infectious Diseases, Bethesda,
Maryland, United StatesWomen’s Health, ME/CFS, Developmental
alcohol exposure on fetal and neonatal brain development
Dr. José E. Manautou, PhD
University of Connecticut Department of Pharmaceutical Sciences,
Storrs, Connecticut, United StatesHepatotoxicity, Model hepatotoxicants
(e.g. acetominophen, carbon tetrachloride), Hepatobiliary disposition of
xenobiotics Hepatoprotection Peroxisome proliferators, Transport proteins
Covalent binding in hepatotoxicity, Reactive intermediates in hepatotoxicity
Ms. Jessica Palmer, M.Sc
Stemina Biomarker Discovery Inc, Madison, Wisconsin, United
StatesCardiotoxicity, Developmental toxicity, Stem cells
Assoc. Professor Terje Svingen, PhD
National Food Institute, Søborg, Denmarktoxicology, testis, sexual
development, sex determination, reproduction, developmental biology,
endocrine disrupting chemicals
Dr. Junichi Tasaki, PhD
Kao Corporation Tochigi Research Center, Haga-gun,
JapanDevelopmental biology, Teratology, Developmental toxicology,
Zebrafish, Planarian, Birth Defects
Dr. Katya Tsaioun, PhD
Johns Hopkins University Bloomberg School of Public Health,
Baltimore, Maryland, United StatesADME, High-content imaging, In
silico, in vitro, Systematic map; Systematic review
Professor Neil Vargesson, PhD
University of Aberdeen School of Medicine Medical Sciences and Nutrition,
Aberdeen, United Kingdom Thalidomide, Birth defects, Vascular
development, Limb development, Chicken embryo, Zebrafish embryo,
Teratogens
Dr. Menghang Xia, PhD All members of the Editorial Board have identified their affiliated
National Center for Advancing Translational Sciences, Bethesda, institutions or organizations, along with the corresponding country
Maryland, United StatesSystems Toxicology, In Vitro or geographic region. Elsevier remains neutral with regard to any
Assoc. Professor Nicole I. Zur Nieden, PhD jurisdictional claims.
University of California Riverside Department of Cell Biology and
Neuroscience, Riverside, California, United StatesEmbryonic Stem Cell,
Osteoblasts, Cell Biology, Molecular Biology
Dr. Dan Villeneuve, PhD
US Environmental Protection Agency, Washington, District of Columbia,
United StatesAquatic ecotoxicology, endocrine disruption, endocrine
physiology, biochemical and molecular toxicology, systems biology, in
vitro bioassays.